Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PSX vs MRNA✓SelectedUSD · MRNAPSX vs MRNA performance historyLatest closeAs of-4.71%11/18
Stock and ETF performance explorer

PSX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+293.6%
MRNA return
-20.0%
Excess return
+313.7%
Maximum drawdown
-44.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.7%-4.8%+0.1%-4.7%
7D-5.4%-20.9%+15.5%-5.1%
30D-15.7%-13.3%-2.5%-15.6%
3M+0.6%+212.6%-212.0%-1.8%
6M+36.9%+309.0%-272.2%+31.8%
YTD+93.7%+567.3%-473.6%+81.4%
1Y+80.6%+689.7%-609.1%+67.4%
3Y+130.2%+157.4%-27.3%+117.8%
5Y+293.6%-21.7%+315.3%+261.7%
All+293.6%-20.0%+313.7%+261.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling